Top investors in Geneve

Showing 1-50 of 80 investors

Venture Kick

Venture Kick is a Swiss accelerator and investment program based in Zurich, established in 2007. It supports early-stage startups, especially those emerging from Swiss universities, by providing staged funding and structured entrepreneurship training. The program uses a three-stage model that includes an initial kick of 10,000 to 150,000 CHF, followed by equity investment and grants. In addition to capital, Venture Kick offers mentorship through Kickers Camps and access to a global network of investors, helping founders refine their business plans and attract further funding. Since its inception, it has supported hundreds of Swiss startup projects, helped create thousands of jobs, and catalyzed substantial subsequent investment in the Swiss startup ecosystem. The initiative aims to bridge the funding gap for high-risk, high-potential ideas and accelerate Swiss innovation.
Made 26 investments in Geneve

Innogest Capital

Innogest Capital is an Italian venture capital firm founded in the mid-2000s that backs early-stage technology and healthcare startups. It maintains offices in Turin and Milan, with a global footprint that includes San Francisco and Geneva. The firm collaborates with local and international research centers and technology transfer offices to support portfolio companies. Its investment focus spans medical devices, diagnostics, and digital health within healthcare, and digital verticals such as foodtech, fintech, fashion-tech and lifestyle in the technology sector. It emphasizes building sustainable, ESG-compliant businesses and leverages a broad network to help entrepreneurs scale, commercialize innovations and access strategic partnerships. Through its networks, Innogest Capital seeks to foster innovation across Europe and beyond while maintaining an early-stage investment approach.
Made 2 investments in Geneve

BlueOcean Ventures

BlueOcean Ventures is a venture capital firm based in Geneva, Switzerland, with an additional office in Zurich. It focuses on early-stage investments in healthcare, life sciences, digital health, nanotechnology, and health technology across Europe, particularly Switzerland and neighboring regions. The firm provides capital as well as operational and company development advisory support, including mentoring, management guidance, networking, and negotiation assistance to entrepreneurs. It maintains an active role in portfolio companies, seeks to leverage a broad network of industry contacts and strategic partners, and collaborates with industry players to support incubation and financing of ventures in healthcare and technology.
Made 1 investment in Geneve

Veris Ventures

Veris Ventures is a venture capital firm founded in 2022 and based in Geneva and Luxembourg. It is an early-stage investor focused on blockchain technology, with investments in cryptocurrency, blockchain startup companies, and Internet of Things applications.

4See Ventures

4See Ventures is a Swiss venture capital firm based in Geneva that backs early-stage startups in healthcare, biotech, medtech, technology, sustainability and climate tech. Founded in 2019, the firm concentrates on Swiss ventures with game-changing potential, emphasizing disruptive innovation, market insight, and anticipation of future trends. It supports entrepreneurs who drive societal impact and transformation, and has invested in companies such as Haya Therapeutics, Transmutex, Distalmotion, and Goodwall.

F2 Ventures

F2 Ventures is a healthcare investment platform and venture capital firm focused on biotechnology arbitrage opportunities. Based in London and Geneva, the firm targets innovative biotechnology companies at pivotal stages to maximize impact and portfolio value. The organization operates in the United Kingdom and pursues opportunities across the biotech sector, with emphasis on strategic timing and value creation.

Medicxi

Medicxi is a venture capital firm focused on the life sciences sector. Founded in 2016 by the former Index Ventures life sciences team, the firm is based in London, United Kingdom, with additional offices in Geneva and Jersey. Medicxi invests across seed, early, and later stages in Europe, targeting therapeutics, biotech, and technology-enabled healthcare companies. Building on decades of experience in drug discovery and development, the team supports ventures across a broad range of therapeutic areas, including vaccines, oncology, and neurology, helping firms advance research, development, and commercialization. The firm originated from Index Ventures and continues to back ambitious startups seeking to translate scientific advances into patient benefit, leveraging a hands-on approach and a network of biopharma partnerships.

Highland Europe

Highland Europe is a venture capital firm headquartered in London that provides growth capital to technology companies in Europe and Israel. The firm focuses on software and consumer-oriented businesses at the growth stage, partnering with management teams to accelerate expansion, scale operations, and build lasting value. Highland Europe pursues a founder-centered, long-term investment approach, offering strategic support and networks alongside capital. Since its inception in 2012, the firm has developed a substantial portfolio across Europe and Israel and maintains an international footprint with offices in London and Geneva. The firm has built a track record of supporting growth-driven companies and managing significant assets, reflecting its role as a leading specialist in cross-border technology investing.

Tayssir Capital

Tayssir Capital is a Geneva-based venture capital firm, established in 2021, that specializes in digital assets investments. The company focuses on identifying and funding opportunities in the digital asset space from its Geneva base, aiming to support early-stage and growth ventures with capital and strategic guidance.

Vinci Capital

Vinci Capital is a Swiss venture capital and private equity firm focused on mid to late venture, succession financing, owner- and management buyouts, spin-offs or carve-outs, and secondary share-backs. It invests in Swiss technology and industrial companies, typically committing CHF 7–10 million per portfolio and targeting firms with annual sales of roughly CHF 20–80 million. The firm seeks opportunities in new media technologies and services, life sciences, microelectronics and nanotechnology, and software and e-Business, and it often takes board seats and can syndicate larger rounds. Founded in 2003 and headquartered in Geneva with an office in Zug, Vinci Capital operates as a subsidiary of Vinci Partners.

Alpana Ventures

Alpana Ventures is a Geneva-based Swiss venture capital firm focused on digital transformation and deep tech. Founded in 2016, it backs founder teams across Europe, Switzerland, and the United States, investing from early stages to growth in sectors such as healthcare, information technology, finance, enterprise software, mobility, cybersecurity, AI, robotics, and cloud gaming. The firm seeks to embed innovative technologies into new or evolving business models to help portfolio companies become global market leaders, and it applies ESG criteria to support sustainable outcomes.

French Partners

French Partners is a venture capital organization and the first co-investment club for qualified investors who support French entrepreneurs internationally. It targets growth-stage startups and SMEs with revenues up to tens of millions of euros and invests typically 1 to 5 million euros per deal, usually as minority stakes, either solo or in co-investment with other funds. The firm relies on a network of serial entrepreneurs and sectoral experts who provide capital and hands-on guidance to help founders scale globally. It embraces the French Diaspora and focuses on international development where the entrepreneur resides, with a francophone network across France and continents including the United States and China. Based in Geneva, Switzerland, French Partners aims to offer access and guidance beyond funding to accelerate international growth.

Alta Berkeley

Alta Berkeley is a London-based venture capital firm founded in 1982 that specializes in early-stage technology investments across Europe, Israel and the United States. The firm backs seed and startup opportunities with a focus on high-technology sectors including software, semiconductor, communication and computing technologies, and medical technology. It typically invests in initial rounds around 1.5 to 3 million pounds and increases to roughly 4 to 8 million as companies advance, often taking a lead role while also co-investing in syndicates. The firm supports portfolio companies through growth and strategic development with an emphasis on helping early-stage ventures scale. Exits are pursued through public offerings, acquisitions or trade sales in the United States and Europe. Alta Berkeley maintains a London headquarters and has had an additional office in Geneva, reflecting a cross-border approach to backing technology ventures. The firm seeks to build value by combining operational guidance with sector expertise to help portfolio companies mature toward scalable commercial success.

Blufolio

Blufolio is a Swiss-based venture capital firm that backs early-stage technology companies operating in blockchain and sustainability sectors. Based in Versoix near Geneva, the firm focuses on leveraging digital and blockchain technologies to address global challenges through sustainable innovation. It builds a diversified portfolio by supporting startups at the intersection of technology and sustainability, making equity investments and, where appropriate, token investments. Blufolio aims to connect the traditional institutional community with blockchain innovation and to advance responsible, scalable solutions.

Reference Capital

Reference Capital is a Geneva, Switzerland-based venture capital advisory firm founded in 2019 that serves institutional and private clients. It delivers bespoke venture capital programs and advisory services, focusing on disruptive technology opportunities through funds of funds, direct investments, and portfolio management. The firm emphasizes a research-driven approach to identifying transformative opportunities and provides end-to-end support, including fund selection, portfolio monitoring, transparent reporting, and ongoing oversight. It has assets under advisement exceeding $1 billion and has completed more than 100 fund investments, and it offers insights through a monthly venture and innovation newsletter.

Climb Ventures

Climb Ventures is a Swiss venture capital firm founded in 2020 and based in Geneva. It backs technology-focused startups across Europe, investing in sectors such as information technology, IoT, advanced manufacturing, fintech, AR, clean tech, e-commerce, gaming, and agtech, with particular attention to Swiss companies pursuing global scale. The firm provides capital, strategic guidance, and access to industry networks to accelerate growth and international expansion, including AI, renewable energy, and digital transformation. Climb targets founders with global ambitions and supports growth to late-stage across digital services, consumer internet, and emerging technologies, leveraging a European footprint to drive market penetration.

Road Ventures

Road Ventures is a Geneva-based venture capital firm founded in 2017 that concentrates on investing in transportation and mobility startups at seed to Series A stages, with a focus on accelerating innovative solutions for future mobility. The firm provides active support to its portfolio companies to help scale technologies such as ride-hailing platforms, AI-enabled travel safety, travel behavior analytics, e-bike sharing, high-speed sustainable transport, and vehicle ownership platforms. Its portfolio includes Alto, Gestoos, MotionTag, Zoov, Zeleros, and Caura.

Lowercarbon Capital

Lowercarbon Capital is a Los Angeles-based venture capital firm that supports climate technology companies across energy, advanced manufacturing and climate resilience. It backs startups from early stages to scale real-world solutions in areas such as carbon capture, renewable energy, sustainable transportation and alternative materials, prioritizing ambitious scientific approaches coupled with commercially viable outcomes. The firm provides hands-on support to portfolio companies and cultivates an ecosystem of founders and industry experts to accelerate the transition to a low-carbon economy, having invested over $200 million across multiple rounds.
Made 2 investments in Geneve

QED Investors

QED Investors is a venture capital firm focused on fintech and financial services, based in Alexandria, Virginia, with offices in New York. Founded in 2007 by former Capital One executives, it invests across all stages from pre-seed to IPO, with a particular strength in Series A opportunities. The firm combines capital with hands-on, operational support and strategic guidance, leveraging deep domain expertise in financial services. It backs startups globally across the US, Europe, Latin America, India, and Asia, and has invested in more than 250 portfolio companies across 27 countries, including about 31 unicorns; notable milestones include leading Credit Karma’s Series A and facilitating its acquisition by Intuit. The firm emphasizes active engagement and a data-driven approach to help portfolio companies navigate the financial services landscape.
Made 2 investments in Geneve

Bosch Ventures

Bosch Ventures is the corporate venture capital arm of the Bosch Group. It invests globally in startup companies at all stages, focusing on automation and electrification, energy efficiency, enabling technologies, and healthcare systems, as well as related services, business models, and new materials relevant to these areas. The firm often syndicates investments with other investors and can lead rounds when necessary. It maintains an international presence with offices in Stuttgart, Frankfurt, Sunnyvale, Tel Aviv, Shanghai, Boston, and London, and supports ventures that advance Bosch's strategic interests by driving technological progress.
Made 1 investment in Geneve

MMC Ventures

MMC Ventures is a London-based venture capital firm that backs early-stage technology companies at seed and Series A, with a focus on enterprise AI, fintech, data-driven health, data infrastructure, and cloud. The firm pursues a research-led approach, aiming to understand each portfolio company’s underlying technology and business model to inform its decisions and support. Beyond capital, MMC Ventures provides founder-focused assistance, including sales introductions and talent support through its MMC CONNECT platform. While its investments span Europe, the firm concentrates on UK opportunities and seeks to be a hands-on partner in building sustainable growth for its portfolio companies.
Made 1 investment in Geneve

Earthshot Ventures

Earthshot Ventures is a San Francisco-based venture capital firm that invests in early-stage companies across AI, infrastructure, energy, and critical minerals. It focuses on Pre-Seed to Series B opportunities worldwide, backing technologies that enable a faster, cheaper, and more sustainable AI economy, including compute efficiency, clean energy, and robust mineral supply chains. The firm targets startups building the materials, power, and compute infrastructure essential to the AI era and aims to help them scale toward large markets and clear impact. It is co-managed with Launch Alaska and emphasizes commercialization and execution to support meaningful climate and economic outcomes.
Made 1 investment in Geneve

Merck Ventures

Merck Ventures is the strategic venture capital unit of Merck. It invests globally in early-stage biotechnology, healthcare, life science tools, electronics, and frontier technologies with the potential to affect Merck’s core business areas. Based in Amsterdam with offices in the United States and Israel, the firm takes an active role in portfolio companies, collaborates with entrepreneurs and co-investors, and pursues company creation and spin-offs to leverage Merck’s science and technology base. With a dual strategic and financial approach, it aims to translate innovation into commercial success and long-term value creation.
Made 5 investments in Geneve

VI Partners

VI Partners is a Swiss venture capital firm focused on healthcare and technology. Founded in 2001, it supports university spin-offs and other promising start-ups with capital, coaching and networks to help bring innovative ideas to market. Based in Altendorf, the firm invests in high-growth healthcare, biotechnology, technology and software companies across Switzerland and Europe, partnering with founders to scale early-stage ventures and translate scientific advances into commercial products. VI Partners emphasizes bridging academia and industry, leveraging its networks to accelerate development and commercialization for portfolio companies.
Made 3 investments in Geneve

Inkef

Inkef is a venture capital firm founded in 2010 and headquartered in Amsterdam, Netherlands, with an additional office in Toronto, Canada. It backs early-stage companies in Europe, particularly in technology, healthcare, and life sciences, and provides long-term support to help businesses grow internationally.
Made 3 investments in Geneve

Verve Ventures

Verve Ventures is a European startup investment platform and venture capital firm that connects qualified private investors and institutional funds with early-stage and growth startups. Founded in 2010 and headquartered in Zug, Switzerland, it maintains a pan-European network with a team in Zurich, Lausanne, Berlin, Paris, and Cambridge. The company's digital platform sources thousands of startup opportunities, conducts rigorous due diligence, and structures rounds to give investors access to high-quality deals. It supports portfolio companies and helps investors diversify exposures to technology-driven ventures across sectors such as energy, computing, healthcare, robotics, cybersecurity, and digital health. Verve Ventures typically invests across seed to Series B and beyond, leveraging its community of private investors, family offices, pension funds, and institutional partners to foster growth across Europe.
Made 5 investments in Geneve

Omega Funds

Omega Funds is a Boston-based venture capital firm founded in 2004 that focuses on investing in life sciences and related technologies. The firm targets opportunities in healthcare and biotech, including digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service, with activity across North America and Western Europe. Omega Funds acts as a registered investment adviser, supporting early-stage and growth companies as they develop therapeutic and digital health solutions.
Made 4 investments in Geneve

DART Ventures

DART Ventures is a Zurich-based venture capital firm established in 2017 that invests in early‑stage B2B technology startups in health, climate, and related sectors across the United States and Europe. It backs Swiss and European teams developing breakthrough solutions in health technology, health consumer tech, food technology, and clean technology, and provides a 12‑month expansion program offering guidance on strategy, culture, fundraising, and go‑to‑market, supported by a network of experienced partners. The firm emphasizes founders and pursues the belief that purpose and profit together drive meaningful impact, with a focus on helping startups succeed in the US market through tailored support and market access.
Made 2 investments in Geneve

Business Angels Switzerland

Business Angels Switzerland is an association of experienced investors who provide capital and mentoring to Swiss startups with high growth potential. The group invests in minority stakes and offers startups access to members' diverse skills, networks, and time as unpaid consultants. Investment decisions are made by individual members, and the association is not a fund or holding company. It organizes regular pitch meetings across Switzerland and fosters a strong community among its members. The focus sectors include consumer goods, retail, biotechnology, ICT, and veterinary technology, with a view to helping startups develop their business and raise capital.
Made 4 investments in Geneve

NMS Capital Group

NMS Capital Group is a private investment firm based in Beverly Hills, California, specializing in private equity, venture capital, and structured financing across a broad range of sectors including business services, consumer products and services, infrastructure, energy and natural resources, insurance, real estate, financial services, manufacturing, and technology. The firm pursues an active, operations-focused approach, partnering with portfolio companies to drive growth through strategic investments, industry best practices, and transformative initiatives.
Made 1 investment in Geneve

CDP Venture Capital

CDP Venture Capital is a leading Italian venture capital fund manager that oversees about €4.9 billion in assets under management across 15 direct and indirect funds. The firm concentrates its investments in sectors integral to Italy’s growth, aiming to place entrepreneurship at the center of economic development. It supports a mature portfolio, pursues ecosystem collaborations to strengthen investments and innovation, and is expanding through new vehicles such as Ulixes and Lumen Ventures' Lumen II, a seed-stage fund focused on insurtech, fintech, digital health, and cybersecurity. CDP maintains a substantial presence in Rome and Milan and offers opportunities through programs like XJOBS. The organization emphasizes transparency through regular investor materials and annual reports, reinforcing its role in advancing the venture capital ecosystem in Italy.
Made 1 investment in Geneve

Union Square Ventures

Union Square Ventures is a New York-based venture capital firm founded in 2003 that focuses on early-stage to growth-stage internet companies. It concentrates on the applications layer of the web, internet services, and web services that create large networks, with emphasis on businesses that generate network effects across sectors such as social media, marketplaces, developer tools, learning, health, fintech, web3 and decentralized systems, technology, and climate. The firm typically makes initial investments around 1 million dollars and can participate in larger rounds up to about 20 million dollars, often taking a lead role and working closely with founders to support growth. It pursues investments across major markets globally, including New York, San Francisco, London, and Berlin.
Made 2 investments in Geneve

Presight Capital

Presight Capital is a venture capital firm founded in 2019 and based in San Francisco, California. It invests in a wide range of sectors, including biotechnology, software as a service, information technology, telecommunications and media, consumer, fintech, cybersecurity, food tech, cryptocurrency, and healthcare, and it supports founders across different stages and geographies.
Made 2 investments in Geneve

Nauta Capital

Nauta Capital is a European venture capital firm headquartered in London, with offices in Barcelona and Munich. Founded in 2004, it invests in early-stage B2B software, enterprise technology, and deep technology companies across Europe.
Made 2 investments in Geneve

Athos Capital

Athos Capital is a venture capital firm based in Madrid, Spain, founded in 2016. It pursues early-stage technology investments across Europe, with a focus on Spain, targeting sectors such as cloud-based farm management software, storage, Internet of Things, corporate accommodation platforms, fintech, and educational technology; the firm has publicly disclosed ESG information and a whistleblower channel as part of its commitment to responsible and transparent operations.
Made 3 investments in Geneve

Nina Capital

Nina Capital is an international venture capital firm based in Barcelona, Spain, specializing in healthcare transformation powered by information technology. Founded in 2019, the firm focuses on early-stage investments from pre-seed to seed+ led by need-driven founders, supported by data and computing resources. Its diverse, multinational team is formed by former healthcare technology founders and operators with deep experience across healthcare and tech sectors. Since inception, Nina Capital has invested in numerous health-tech companies across multiple regions, aiming to improve patient outcomes worldwide. The firm explicitly excludes investments in drugs and vaccines.
Made 2 investments in Geneve

Serpentine Ventures

Serpentine Ventures is the venture capital arm of the Swiss Ventures Group, based in Zurich, Switzerland. Founded in 2019, it concentrates on European information technology and software-as-a-service investments, providing early and growth funding to promising technology companies. The firm supports founding teams with strategic guidance and operational input while leveraging the Swiss group's networks to help portfolio companies scale. As an arm of a broader Swiss startup ecosystem, Serpentine Ventures aims to back ventures with strong tech propositions and scalable business models across the European market.
Made 2 investments in Geneve

Syncona

Syncona is a London-based life sciences investment company that builds and supports businesses developing treatments for serious diseases. It focuses on areas including gene and cell therapy, and works with scientific teams to advance innovative treatments for patients with significant unmet needs. Syncona invests globally.
Made 1 investment in Geneve

Gaingels

Gaingels is a venture investment syndicate focused on supporting LGBTQ+ founders and leaders, investing in companies across stages and sectors and prioritizing inclusive teams and governance. It operates a global portfolio of companies and provides capital alongside resources to recruit diverse talent for C-suite and board roles. The network emphasizes collaboration among investors, operators, and entrepreneurs to advance positive social change through business.
Made 1 investment in Geneve

Amboy Street Ventures

Amboy Street Ventures is a Los Angeles-based venture capital firm founded in 2021 that concentrates on early-stage investments in women’s health and sexual wellness technology. The firm backs seed and Series A rounds for startups addressing fertility, menopause, maternal health, menstrual health, hormonal health, contraception, and broader sexual health and wellbeing, with activity across the United States and Europe. Its portfolio emphasizes inclusive solutions spanning all genders and aims to accelerate innovation in a substantial, multisector market by supporting companies that improve health outcomes and access in women’s health and sexual wellbeing.
Made 1 investment in Geneve

Servier

Servier is a global pharmaceutical group focused on patient-centric innovation across cancers, cardio-metabolism and neurology, powered by a robust R&D engine and the Institut R&D Servier Paris-Saclay. It maintains a diverse development pipeline including clinical and third-party sponsored studies and an access program for patients. The company advances collaboration and patient access through Servier Ventures, has invested in Cytospire Therapeutics and completed the acquisition of Day One Biopharmaceuticals to strengthen its oncology portfolio, and it is pursuing strategic options such as the planned sale of Biogaran. Its global footprint is complemented by commitments to ethics, transparency and sustainability, and it actively engages patients and caregivers to co-design therapies that address real needs.
Made 1 investment in Geneve

House Of Ventures

Founded in 2022, House Of Ventures is an investment and advisory firm serving next-generation investors. It connects capital with venture opportunities, particularly in technology, and offers education, networking, and support to investors and portfolio companies. Sources identify Los Angeles and San Francisco as its base locations.
Made 1 investment in Geneve

At One Ventures

At One Ventures is a San Francisco-based venture capital firm that backs early-stage companies using deep technology to reduce environmental harm or restore nature. It invests in areas including energy, food and agriculture, clean technology, and solutions for air, water, soil, and biodiversity.
Made 1 investment in Geneve

Hardware Club

Hardware Club is a venture capital firm that targets seed-stage investments in hardware and hardtech companies, providing capital and an ecosystem of resources to founders. Headquartered in Paris with a global reach, it engages with startups across the United States and Europe and maintains a community of more than 500 startups, offering partnerships and events to help scale businesses in areas such as digital health, artificial intelligence, sensors, connected devices, smart buildings, and related hardware-enabled technologies.
Made 1 investment in Geneve

Tiny Supercomputer Investment Company

Tiny Supercomputer Investment Company is a venture capital firm focused on early-stage technology startups in Europe. Since 2017 it has invested roughly 200-250k in pre-seed and seed rounds, primarily from bases in London with a presence in Berlin. The firm operates as a supportive partner, avoiding board seats and not leading rounds, and it collaborates with founders through a community of over 900 founders to help navigate investor relations, problem-solving and decision-making. The team comprises experienced partners specializing in investing, fundraising, operations and legal, enabling strategic guidance and practical support throughout the early growth stages.
Made 1 investment in Geneve

Index Ventures

Founded in 1996, Index Ventures is a venture capital firm headquartered in London, with offices in San Francisco and Geneva. It invests in early-stage and growth-stage technology companies across areas including software, fintech, healthcare, consumer services, and life sciences, and works with founders as their businesses develop and expand. The firm invests internationally, including across Europe and the United States.
Made 1 investment in Geneve

Broadhaven Ventures

Broadhaven Ventures is a fintech-focused investment company that also operates as a branding and web studio. It invests its own capital in fintech startups and remains engaged with portfolio companies beyond the initial round, providing strategic and operational support alongside branding, design, and product development services. The firm collaborates with banks, fintechs, and financial services players to accelerate innovation and drive market structure evolutions, emphasizing robust financial infrastructure and customer-focused concepts. Through its combined investment and creative services, Broadhaven seeks to build and scale market leaders across consumer and enterprise fintech sectors.
Made 1 investment in Geneve

LIFTT

LIFTT is a Europe-based venture capital holding founded in 2019 and focused on deep-tech investments across multiple verticals, including human health and aging, critical resources, infrastructure for the data revolution, energy security, and industrial automation. Based in Turin, Italy, the firm acts as a catalyst to translate advanced scientific research into high-impact companies by connecting ideas, talent, territories and financial resources, pursuing an active, multi-vertical approach to foster innovation across Europe and beyond.
Made 1 investment in Geneve

Panakes Partners

Panakes Partners is an independent venture capital firm based in Milan, Italy, focused on early-stage investments in life sciences and healthcare across Europe and Israel. Founded in 2015, it backs ambitious teams developing innovative therapies and technologies with the goal of improving patient outcomes. The firm emphasizes partnering with portfolio companies through its extensive network of clinicians and industry experts, providing strategic guidance and operational support to accelerate development across therapeutic areas such as dermatology, surgery, ophthalmology, cardiology, oncology, biotechnology, and neurostimulation.
Made 1 investment in Geneve

OCCIDENT

OCCIDENT is a Munich- and Zug-based venture capital firm that backs deep-tech start-ups and spin-offs from scientific research. It invests its own capital from the seed stage and provides long-term, hands-on support in life sciences and industrial tech, combining financial backing with extensive experience to help teams translate breakthroughs into scalable solutions. The firm operates with an owner-managed structure and emphasizes a science-driven approach and close collaboration with founders to pursue sustainable growth and societal impact. Its portfolio has included notable momentum, such as Tubulis, acquired by Gilead in 2026, and Immitra Bio, which raised early-stage funding in 2026, reflecting a focus on transformative technologies.
Made 1 investment in Geneve